These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide. Kanemura T; Tamaoki J; Chiyotani A; Takeyama K; Sakai N; Tagaya E; Konno K Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):11-22. PubMed ID: 8381977 [TBL] [Abstract][Full Text] [Related]
23. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo. Rubinstein I; Ashok B; Tsueshita T; Onyüksel H Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658 [TBL] [Abstract][Full Text] [Related]
24. The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea. Webber SE; Widdicombe JG Br J Pharmacol; 1987 May; 91(1):139-48. PubMed ID: 3594072 [TBL] [Abstract][Full Text] [Related]
25. Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin, and PACAP. Du K; Nicole P; Couvineau A; Laburthe M Ann N Y Acad Sci; 1998 Dec; 865():386-9. PubMed ID: 9928035 [No Abstract] [Full Text] [Related]
26. On muscarinic control of neurogenic mucus secretion in ferret trachea. Ramnarine SI; Haddad EB; Khawaja AM; Mak JC; Rogers DF J Physiol; 1996 Jul; 494 ( Pt 2)(Pt 2):577-86. PubMed ID: 8842014 [TBL] [Abstract][Full Text] [Related]
27. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
28. VIP and PACAP potentiation of nicotinic ACh-evoked currents in rat parasympathetic neurons is mediated by G-protein activation. Liu DM; Cuevas J; Adams DJ Eur J Neurosci; 2000 Jul; 12(7):2243-51. PubMed ID: 10947803 [TBL] [Abstract][Full Text] [Related]
29. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855 [TBL] [Abstract][Full Text] [Related]
30. Pituitary adenylate cyclase activating peptide mediates inhibitory nonadrenergic noncholinergic relaxation. Yoshida M; Aizawa H; Takahashi N; Shigyo M; Hara N Eur J Pharmacol; 2000 Apr; 395(1):77-83. PubMed ID: 10781677 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter. Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737 [TBL] [Abstract][Full Text] [Related]
32. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs. Naruse S; Suzuki T; Ozaki T Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389 [TBL] [Abstract][Full Text] [Related]
34. Action of pituitary adenylate cyclase-activating polypeptide on ion transport in guinea pig distal colon. Kuwahara A; Kuwahara Y; Mochizuki T; Yanaihara N Am J Physiol; 1993 Mar; 264(3 Pt 1):G433-41. PubMed ID: 8384795 [TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433 [TBL] [Abstract][Full Text] [Related]
36. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat. Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062 [TBL] [Abstract][Full Text] [Related]
37. Modulation of cholinergic neurotransmission by vasoactive intestinal peptide in ferret trachea. Sekizawa K; Tamaoki J; Graf PD; Nadel JA J Appl Physiol (1985); 1988 Jun; 64(6):2433-7. PubMed ID: 2841273 [TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681 [TBL] [Abstract][Full Text] [Related]
39. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411 [TBL] [Abstract][Full Text] [Related]
40. Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum. Fujimiya M; Yamamoto H; Kuwahara A Am J Physiol; 1998 Oct; 275(4):G731-9. PubMed ID: 9756504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]